Global Healthcare, Regulatory and Reimbursement Landscape Forecasts and Trends in UAE, Canada and Taiwan
FARMINGTON, Conn., Nov. 26, 2012 /PRNewswire-iReach/ -- The healthcare system in the United Arab Emirates is characterized by high public expenditure on implementation of healthcare policies and expanding private infrastructure to offer more sophisticated facilities. Taiwan's healthcare system is characterized by three positive trends: a growing elderly population, universal healthcare insurance, and a high degree of access to healthcare facilities. In Canada, government initiatives for the prevention and management of chronic diseases in addition to strong, efficient, and transparent guidelines that simplify the regulatory process differentiate the positive trends in the Canadian healthcare market.
Global Information Inc (GII) is pleased to present three market research reports covering the healthcare, regulatory and reimbursement market landscapes in the UAE, Canada, and Taiwan from our premium research partner, GlobalData.
Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates
The UAE is the second largest country in the Middle East in terms of capital invested in the pharmaceutical sector. Its pharmaceutical market was worth $1 billion in 2006 and is estimated to reach approximately $3.7 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 9.8% (Kulkarni, 2010). The growing popularity of medical tourism is the main contributor to market growth, as well as factors such as the growing elderly population.
The medical device market in the UAE was worth approximately $541.1m in 2006 and is estimated to reach $979m by 2020 at a CAGR of 4.3%. Key growth drivers of UAE's medical device market are increasing public and private wealth fuelled by the oil boom, the absence of significant local competition and a strong and growing healthcare infrastructure.
This report will benefit executives by explaining the trends shaping and driving the healthcare market in United Arab Emirates to help them develop better business strategies, drive revenues, formulate effective sales and marketing plans, and identify, understand and capitalize on the opportunities and challenges in the healthcare market.
An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/gd254866-healthcare-regulatory-reimbursement-landscape.html
Healthcare, Regulatory and Reimbursement Landscape – Canada
Canada's population was approximately 34.4 million in 2011, and is growing largely as a result of immigration. The natural growth rate of the population is projected to be low due to the balance between the mortality and birth rates. The increasing elderly population, however, is a matter of concern for policy planners.
According to the report, the pharmaceutical market in Canada was valued at about $21.5 billion in 2010 and is expected to reach approximately $45.9 billion by 2020, at a projected 9.9% CAGR. The medical device market was valued at approximately $7.7 billion in 2011 and is expected to reach approximately $12.2 billion by 2020, at a projected 5.2% CAGR.
This report identifies key trends in the Canadian healthcare market, and also provides insights on the demographic, regulatory, and reimbursement landscape, as well as the healthcare infrastructure. Most importantly, the report provides valuable insights on the trends and segmentation of the pharmaceutical and medical devices markets.
An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/gd251028-healthcare-regulatory-reimbursement-landscape.html
Healthcare, Regulatory and Reimbursement Landscape – Taiwan
The market for medical devices in Taiwan is one of the largest in Asia. It was valued at approximately $1.6 billion in 2006 and grew at a CAGR of 5.1% to $1.9 billion in 2011. It is predicted to reach $3 billion by 2020.
The scope of this report includes: an overview of Taiwan's pharmaceutical and medical device markets; profiles and SWOT analyses of major players in the pharmaceutical and medical device markets; review of the reimbursement and regulatory landscape; detailed analysis of Taiwan's political and economic environment; and an overview of the opportunities and challenges.
An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/gd250471-healthcare-regulatory-reimbursement-landscape.html
About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.
SOURCE Global Information, Inc.
More by this Source
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.